Festal - 40 dragees, three-component enzyme agent
Category
Preparations for the gastrointestinal tract
Scope of the medicinal product
Gastrointestinal tract
Release form
Dragee
Manufacturer country
India
Package quantity, pcs
40
White, glossy, round dragees with a faint vanilla smell.
pharmachologic effect
The drug compensates for the lack of exocrine pancreatic function due to pancreatin, and the biliary function of the liver due to the bile component.
Festal has proteolytic, amylolytic and lipolytic effects.
Enzymes included in pancreatin: amylase, lipase and protease facilitate the digestion of carbohydrates, fats and proteins, which contributes to their more complete absorption in the small intestine.
And in this respect, Festal practically does not differ from other enzyme preparations.
The presence of bile acids in Festal gives the drug additional opportunities for correcting biliary insufficiency, which often accompanies chronic pancreatitis.
Bile extract acts as a choleretic, facilitates the absorption of fats and fat-soluble vitamins A, E and K, promotes the release of lipase by the pancreas.
The enzyme hemicellulase promotes the breakdown of plant fiber, which also improves digestive processes, reduces the formation of gases in the intestines.
Name ENG
FESTAL
Clinical and pharmacological group
Enzyme preparation
ATX code
A09AA02
Dosage
Pancreatin - 192 mg equivalent (amylase - 4500 FIP U, lipase - 6000 FIP U, protease -
300 FIP UNITS)
Hemicellulase - 50 mg
Bile components - 25 mg
Structure
Core composition
Active substances:
Pancreatin - 192 mg equivalent (amylase - 4500 FIP U, lipase - 6000 FIP U, protease -
300 FIP UNITS)
Hemicellulase - 50 mg
Bile components - 25 mg
Excipients: sodium chloride
Indications
Insufficiency of exocrine pancreatic function in chronic
pancreatitis in combination with biliary insufficiency due to various
pathological conditions, clinically manifested by impaired digestion of food,
flatulence, a tendency to constipation, as part of a combination therapy for:
- diffuse liver diseases - alcoholic and toxic liver damage, cirrhosis
liver
- large losses of bile acids (in patients after cholecystectomy)
- violation of the circulation of bile acids, observed with dyskinesias
biliary tract, dysbiosis, malabsorption
- violation of neurohumoral regulation of the processes of bile formation and bile secretion
with chronic diseases of the gastrointestinal tract - chronic gastritis,
chronic duodenitis, chronic cholecystitis
INN / Active ingredient
Pancreatin
Hemicellulase
Bile components
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 3 years
Contraindications
Hypersensitivity to the components of the drug, acute pancreatitis,
exacerbation of chronic pancreatitis, liver failure, hepatic coma
or precoma, hepatitis, hyperbilirubinemia, obstructive jaundice, gallstone
disease, empyema of the gallbladder, intestinal obstruction, tendency to diarrhea,
children's age up to 3 years, pregnancy and the period of breastfeeding.
Specifications
Category
Preparations for the gastrointestinal tract
Scope of the medicinal product
Gastrointestinal tract
Release form
Dragee
Manufacturer country
India
Package quantity, pcs
40
Scope of application
Gastroenterology
Minimum age from
3 years old
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Sanofi
The amount of the dosage form in the primary package
10 pieces.
Primary packaging type
Cell-free contoured packaging (strip)
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Digestive Enzyme Remedy
Anatomical and therapeutic characteristics
A09AA02 Polyenzyme preparations (lipase + protease, etc.)
Dosage form
Dragee
Dosage (volume) of the substance in the preparation
192 mg + 50 mg + 25 mg
Expiration date in days
1095
The target audience
Children
Package weight, g
twenty
Mode of application
:
Inside.
The drug is taken orally, without chewing, during or immediately after a meal, with a drink.
a little liquid.
Assign 1-2 pills 3 times a day.
Higher doses are prescribed only by a doctor.
The dosage and dosage regimen in children is determined by the doctor.
The duration of treatment can vary from several days (in case of violation
the digestive process due to errors in the diet) up to several months or years (with
the need for constant substitution therapy).
Before X-ray or ultrasound examination - 2 tablets 2-3 times a day
2-3 days before the study.